Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
xiang bin fang
- Development stage
- Preclinical
- Administration
- Oral
01
Overview
Xiang Bin Fang (香槟方) is a traditional Chinese herbal formula composed of several herbs, including Amomum villosum (砂仁), Lindera aggregata (乌药), Panax ginseng (人参片), Prunus persica (桃仁), and Areca catechu (槟榔). It is primarily used to promote gastrointestinal motility and enhance recovery of gastrointestinal function, particularly in the perioperative period. Mechanistically, Xiang Bin Fang has been shown to increase plasma motilin levels by acting on Mo cell receptors, thereby stimulating gastric motility and improving digestive function[8][1]. The formula is studied for its role in accelerating postoperative recovery of gastrointestinal function.
- Other names
- 香槟方
02
Targets
MLNR (Human motilin receptor)
Beyond the preview
Go deeper on xiang bin fang.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on xiang bin fang.